This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-Aventis Recherche & Développement. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Philippe Beauverger: Innovator in Therapeutic Solutions
Introduction
Philippe Beauverger is a notable inventor based in Paris, France. He has made significant contributions to the field of therapeutic innovations. His work primarily focuses on the development of receptor agonists, which play a crucial role in various medical therapies.
Latest Patents
Philippe Beauverger holds a patent for "CRF2 Receptor Agonists and Their Use in Therapy." This patent highlights his innovative approach to addressing therapeutic needs through receptor modulation. His expertise in this area has the potential to impact treatment methodologies significantly.
Career Highlights
Beauverger is associated with Sanofi-Aventis Recherche & Développement, a leading pharmaceutical company. His role within the organization allows him to collaborate with other experts in the field, enhancing the development of new therapeutic solutions. His career reflects a commitment to advancing medical science through innovative research.
Collaborations
Philippe Beauverger has worked alongside talented colleagues such as Stéphane Illiano and Laurence Lucats. These collaborations have fostered a productive environment for innovation and research, contributing to the success of their projects.
Conclusion
Philippe Beauverger's contributions to the field of therapy through his patent and work at Sanofi-Aventis Recherche & Développement exemplify the impact of dedicated inventors in advancing medical science. His innovative spirit continues to inspire future developments in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile